A Trial to Compare Blood Concentration Levels of Semaglutide Following Subcutaneous Injections of Semaglutide 1 mg by 2 Different Devices (the DV3372 Device and by the PDS290 Semaglutide Pen-injector)
Clinical trial NCT03611322 · COMPLETED
Trial details
- NCT number
- NCT03611322
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-08
- Primary completion
- 2019-01-07
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.